Literature DB >> 15472229

Specificity and regioselectivity of the conjugation of estradiol, estrone, and their catecholestrogen and methoxyestrogen metabolites by human uridine diphospho-glucuronosyltransferases expressed in endometrium.

Johanie Lépine1, Olivier Bernard, Marie Plante, Bernard Têtu, Georges Pelletier, Fernand Labrie, Alain Bélanger, Chantal Guillemette.   

Abstract

Uridine diphospho-glucuronosyltransferases (UGTs) inactivate and facilitate the excretion of estrogens to glucuronides (-G), the most abundant circulating estrogen conjugates. The identity of the conjugated estrogens formed by all known overexpressed UGTs (n = 16) was analyzed by comparison with retention time and mass fragmentation of authentic standards by HPLC tandem mass spectrometry methods. Six UGTs, namely 1A1, 1A3, 1A8, 1A9, 1A10, and 2B7, were found to glucuronidate estradiol (E(2)) and estrone (E(1)), their hydroxyls (OH), and their methoxy derivatives (MeO). Addition of glucuronic acid was catalyzed by specific UGTs at positions 2, 3, and 4 of the estrogens, whereas only E(2) was conjugated at position 17 by UGT2B7. Kinetic parameters indicate that the conjugation of E(2) at position 3 was predominantly catalyzed by 1A1, 1A3, and 1A8 and by 1A8 for E(1). Conjugation of 2-OHE(1)/E(2) and 2- and 4-MeOE(1)/E(2) was selective at position 3, mostly catalyzed by 1A1 and 1A8. Of all UGTs, UGT2B7 demonstrated the highest catalytic activities for estrogens and at least 10- to 50-fold higher activity for the conjugation of genotoxic 4-hydroxycatecholestrogens at position 4, compared with the conjugation of E(2), E(1), and 2-hydroxycatecholestrogens. Its presence was further shown in the endometrium by RT-PCR and immunohistochemistry, localizing in the same cells expressing CYP1B1, involved locally in the formation of 4-hydroxycatecholestrogens. Data show that several UGT enzymes detected in the endometrium are involved in the glucuronidation of E(2) and its 2-OH, 4-OH, and 2-MeO metabolites that exert various biological effects in the tissue.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15472229     DOI: 10.1210/jc.2004-0331

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  32 in total

1.  Associations between polymorphisms in glucuronidation and sulfation enzymes and sex steroid concentrations in premenopausal women in the United States.

Authors:  Mellissa Yong; Stephen M Schwartz; Charlotte Atkinson; Karen W Makar; Sushma S Thomas; Frank Z Stanczyk; Kim C Westerlind; Katherine M Newton; Victoria L Holt; Wendy M Leisenring; Johanna W Lampe
Journal:  J Steroid Biochem Mol Biol       Date:  2010-12-28       Impact factor: 4.292

2.  Correlation between bilirubin glucuronidation and estradiol-3-gluronidation in the presence of model UDP-glucuronosyltransferase 1A1 substrates/inhibitors.

Authors:  Jin Zhou; Timothy S Tracy; Rory P Remmel
Journal:  Drug Metab Dispos       Date:  2010-10-28       Impact factor: 3.922

Review 3.  Human steroid biosynthesis, metabolism and excretion are differentially reflected by serum and urine steroid metabolomes: A comprehensive review.

Authors:  Lina Schiffer; Lise Barnard; Elizabeth S Baranowski; Lorna C Gilligan; Angela E Taylor; Wiebke Arlt; Cedric H L Shackleton; Karl-Heinz Storbeck
Journal:  J Steroid Biochem Mol Biol       Date:  2019-07-27       Impact factor: 4.292

4.  Phenylalanine(90) and phenylalanine(93) are crucial amino acids within the estrogen binding site of the human UDP-glucuronosyltransferase 1A10.

Authors:  Athena Starlard-Davenport; Yan Xiong; Stacie Bratton; Anna Gallus-Zawada; Moshe Finel; Anna Radominska-Pandya
Journal:  Steroids       Date:  2006-12-15       Impact factor: 2.668

5.  Modulation of the human glucuronosyltransferase UGT1A pathway by splice isoform polypeptides is mediated through protein-protein interactions.

Authors:  Judith Bellemare; Mélanie Rouleau; Mario Harvey; Chantal Guillemette
Journal:  J Biol Chem       Date:  2009-12-08       Impact factor: 5.157

6.  Multiplexed Targeted Quantitative Proteomics Predicts Hepatic Glucuronidation Potential.

Authors:  Guillaume Margaillan; Michèle Rouleau; Kathrin Klein; John K Fallon; Patrick Caron; Lyne Villeneuve; Philip C Smith; Ulrich M Zanger; Chantal Guillemette
Journal:  Drug Metab Dispos       Date:  2015-06-15       Impact factor: 3.922

Review 7.  Implication of environmental estrogens on breast cancer treatment and progression.

Authors:  Thomas L Gonzalez; James M Rae; Justin A Colacino
Journal:  Toxicology       Date:  2019-03-30       Impact factor: 4.221

8.  Evaluation of 3,3',4'-trihydroxyflavone and 3,6,4'-trihydroxyflavone (4'-O-glucuronidation) as the in vitro functional markers for hepatic UGT1A1.

Authors:  Baojian Wu; Shuxing Zhang; Ming Hu
Journal:  Mol Pharm       Date:  2011-10-21       Impact factor: 4.939

9.  Prevalence of the UGT1A1*28 promoter polymorphism and breast cancer risk among African American women in Memphis, TN.

Authors:  Alana Smith; Cheryl D Cropp; Gregory Vidal; Elizabeth Pritchard; Jennifer Cordero; Claire Simpson; Athena Starlard-Davenport
Journal:  Cancer Health Disparities       Date:  2019-08-19

10.  Genetic variations in UGT1A1 and UGT2B7 and endometrial cancer risk.

Authors:  Monica McGrath; Johanie Lepine; I-Min Lee; Lyne Villeneuve; Julie Buring; Chantal Guillemette; Immaculata De Vivo
Journal:  Pharmacogenet Genomics       Date:  2009-03       Impact factor: 2.089

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.